Sign in
4

Changes in Ownership

Tango Therapeutics, Inc. Filed Acc 0000899243-22-004604

Options or other derivatives

  • Chief Financial Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Beckman Daniella · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-02-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,000 $9.22 2032-02-01 150,000 150,000 D
Loading xslF345X03/doc4.xml…